The American Society of Clinical Oncology (ASCO) is a professional oncology society committed to conquering cancer through research, education, prevention, and the delivery of high-quality patient ...
ASCO Breakthrough gathers global oncology professionals in Asia, offering tailored scientific sessions, invaluable connections built on a shared purpose, and practical strategies to directly improve ...
The QOPI® Certification Program (QCP™) application is available in the ASCO Care Delivery Portal for new and re-certifying practices. For step-by-step application instructions, please refer to the QCP ...
The MedOnc ITE is a low-stakes, 6-hour, 200-question exam intended for self-evaluation and program improvement. It is a teaching tool designed to provide a snapshot of trainee knowledge and program ...
SPARGO, Inc. is the only official registration and housing provider for ASCO Meetings and Symposia. Individuals unaffiliated with ASCO or SPARGO, Inc. may entice prospective attendees into registering ...
ASCO members are invited to help define the educational content for our flagship meetings. Through our new, unified submission portal, members can submit proposals that address the most critical needs ...
Online registrations are processed securely and confirmed immediately by email. Below you will find information related to registration fees, special rate categories, registration changes, and ...
Robin T. Zon, Erin B. Kennedy, Kerin Adelson, Sibel Blau, Natalie Dickson, David Gill, Nicole Laferriere, Ana Maria Lopez, Therese M. Mulvey, Debra Patt, Todd A ...
ASCO stands with our Ukrainian members, the worldwide oncology community, and health care providers around the globe in condemning Russia’s unprovoked war on Ukraine. We call for an immediate ...
The American Society of Clinical Oncology (ASCO) today released a position statement on state drug repository programs, outlining ASCO’s support for drug repository programs solely for oral ...
Today, the Advisory Committee on Immunization Practices (ACIP) voted to end its recommendation of the universal birth dose of the Hepatitis B (HepB) vaccine and instead recommend the birth dose only f ...
The 2022 Conversion Factor (CF) will be $33.59, a decrease of $1.30 from the 2021 PFS conversion factor of $34.89. This 3.7% reduction in the CF is largely due to the expiration of the 3.75% temporary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results